Cost-effectiveness analysis of a postoperative clinical care pathway in head and neck surgery with microvascular reconstruction

Journal of Otolaryngology - Head and Neck Surgery

Volumn 42, Issue DEC, 2013, Pages

  Dautremont, Jonathan F ^a   Rudmik, Luke R ^a   Yeung, Justin ^a   Asante, Tiffany ^a   Nakoneshny, Steve C ^a   Hoy, Monica ^a   Lui, Amanda ^a   Chandarana, Shamir P ^a   Matthews, Thomas W ^a   Schrag, Christiaan ^a   Dort, Joseph C ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b HRIC 2A02 ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CLINICAL PATHWAY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FINANCIAL MANAGEMENT; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; HEAD AND NECK TUMOR; MICROSURGERY; MIDDLE AGED; PLASTIC SURGERY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; CRITICAL PATHWAYS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LENGTH OF STAY; MALE; MICROSURGERY; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 84897004052     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.1186/1916-0216-42-59     Document Type: Article

References (26)

1. Lang K, Menzin J, Earle CC, Jacobson J, Hsu M: The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg 2004, 130(11):1269-1275.
2. Organization for Economic Cooperation and Devolopment: Health Data 2011 - How Does Canada Compare. OECD.org; 2012.from: www.oecd.org/health/ healthdata2011.htm.
3. Chen AY, Callender D, Mansyur C, Reyna K, Limitone E: The impact of clinical pathways on the practice of head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg 2000, 126:332-326.
4. Hanna E, Schultz S, Doctor D, Vural E, Stern S, Suen J: Development and implementation of a clinical pathway for patients undergoing total laryngectomy: impact on cost and quality of care. Arch Otolaryngol Head Neck Surg 1999, 125:1247.1251.
5. Jones NF, Jarrahy R, Song JI, Kaufman MR, Markowitz B: Postoperative medical complications-not microsurgical complications-negatively influence the morbidity, mortality, and true costs after microsurgical reconstruction for head and neck cancer. Plast Reconstr Surg 2007, 119:2053-2060.
6. McCulloch TM, Jensen NF, Girod DA, Tsue TT, Weymuller EA Jr: Risk factors for pulmonary complications in the postoperative head and neck surgery patient. Head Neck 1997, 19:372-377.
7. Rao MK, Reilley TE, Schuller DE, Young DC: Analysis of risk factors for postoperative pulmonary complications in head and neck surgery. Laryngoscope 1992, 102:45-47.
8. Petrar S, Bartlett C, Hart RD, MacDougall P: Pulmonary complications after major head and neck surgery: a retrospective cohort study. Laryngoscope 2012, 122:1057-1061.
9. BuSaba NY, Schaumberg DA: Predictors of prolonged length of stay after major elective head and neck surgery. Laryngoscope 2007, 117:1756-1763.
10. Kaplan R, Anderson S: Time-driven activity-based costing: a simpler and more powerful path to higher profits. US: Harvard Business School Publishing Corporation; 2007.
11. Kaplan RS, Porter ME: The big idea: How to solve the cost crisis in health care. Harvard Business Review; 2011. http://hbr.org/2011/09/how-to-solve- thecost-crisis-in-health-care/ar/1.
12. Brookes J, Seikaly H, Diamond C, Mechor B, Harris JR: Prospective randomized trial comparing the effect of early suturing of tracheostomy sites on postoperative patient swallowing and rehabilitation. J Otol 2006, 35(2):77-82.
13. Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. 2nd edition. Oxford, New York, Toronto: xford Medical Publications, Oxford University Press; 1997:96-131.
14. Kobelt G: Health Economics: An Introduction to Economic Evaluation. 2nd edition. London, UK: Office of health economics; 2002:56-72.
15. Tess BH, Glenister M, Rodrigues C, Wagner: Incidence of hospital-acquired infection and length of hospital stay. Eur J Clin Micriobio Infect Dis Feb. 1996, 12(2):81-88.
16. Woolhandler S, Campbell T, Himmelstein DU: Costs of health care administrationin the United States and Canada. N Engl J Med 2003, 349:768-775.
17. Heacock D, Brobst R: A multidisciplinary approach to critical path development: a valuable CQI tool. J Nurs Care Qual July 1994, 8:38-41.
18. Husbands JM, Weber RS, Karpati RL: Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg 1999, 121:755.759.
19. Gendron M, Lai S, Weinstein G, Chalian C: Clinical care pathway of head and neck cancer. A valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg 2002, 128:258-262.
20. Eichenberger A-S, Haller G, Cheseaux N, Lechappe V, Garnerin P, Walder B: A clinical pathway in a post-anaesthesia care unit to reduce length of stay, mortality and unplanned intensive care unit admission. Eur J Anaesthesiol 2011, 28(12):859-866.
21. Smeele LE, Goldstein D, Tsai V, Gullane PJ, Neligan P, Brown D, Irish JC: Morbidity and cost differences between free flap reconstruction and pedicled flap reconstruction in oral and oropharyngeal cancer: matched control study. J Otol 2006 Apr, 35(2):102-107.
22. Novakovic D, Patel RS, Goldstein DP, Gullane PJ: Salvage of failed free flaps used in head and neck reconstruction. Head Neck Oncol 2009 Aug. 21, 1:33.
23. Petrar S, Bartlett C, Hart RD, MacDougall P: Pulmonary complications after major head and neck surgery: a retrospective cohort study. Laryngoscope 2012 May, 122(5):1057-1061
24. Amonkar MM, Chastek B, Samant N, Teitelbaum A: Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population. J Med Econ 2011, 14(4):421-432.
25. Funk GF, Karnell LH, Whitehead S, Paulino A, Ricks J, Smith RB: Free tissue transfer versus pedicled flap cost in head and neck cancer. Otolaryngol - Head and Neck Surg 2002, 127:205-212.
26. Barnett PG: An improved set of standards for finding cost for cost-effectiveness analysis. Med Care 2009 Jul, 47 (7 Suppl 1):S82-S88